Clinical behavioral pharmacology: methods for evaluating medications and contingency management.
We evaluated methods for comparing the effects of dextroamphetamine (Dexedrine), thioridazine (Mellaril), and contingency management in the control of severe behavior problems. A reversal design was used in which medications were systematically titrated and assessed in unstructured as well as structured settings with three clients. Subsequently, behavioral procedures including timeout, differential reinforcement of other behavior, and visual screening, were used in a multiple-baseline design across settings. The assessment and design methods were useful in comparing the interventions. Dextroamphetamine decreased inappropriate behaviors and improved academic behaviors in one client, but no reliable effects were observed in the other two clients. Thioridazine was variable across clients, settings, behaviors, and dosages. Contingency management produced consistent decreases in inappropriate behaviors and small improvements in academic performance.
D000124:Achievement; D000328:Adult; D000374:Aggression / Q000187:drug effects; D001288:Attention / Q000187:drug effects; D001521:Behavior Therapy / Q000379:methods*; D002648:Child; D003913:Dextroamphetamine / Q000627:therapeutic use*; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy* / Q000534:rehabilitation; D008297:Male; D012055:Reinforcement Schedule; D013239:Stereotyped Behavior / Q000187:drug effects; D013881:Thioridazine / Q000627:therapeutic use*
D013881:Thioridazine; D003913:Dextroamphetamine